Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Omicron isn’t fatal, but India should be prepared for third wave: Expert

by AIP Online Bureau | Dec 4, 2021 | Eco/Invest/Demography, Facts, Health, Pandemic

“It might be a mild disease. It is possibly being observed in some countries such as South Africa that the gap between the infection and the manifestation of the disease is a little longer. And when it is longer than the Delta virus, it is likely to be...

Maharashtra man tests positive for Omicron; India’s fourth case

by AIP Online Bureau | Dec 4, 2021 | Health, Indian News, Non-Life, Pandemic, Workplace/Employee Benefits

Cases with the Omicron variant have already been detected in Karnataka and Gujarat Mumbai: A 33-year-old man from Thane district near Mumbai who had arrived at the Delhi airport from South Africa via Dubai before flying to the Maharashtra capital has tested positive...
Omicron Spreads To 38 Nations, No Deaths Reported, Says WHO

Omicron Spreads To 38 Nations, No Deaths Reported, Says WHO

by AIP Online Bureau | Dec 4, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic, Workplace/Employee Benefits

The World Health Organization has warned it could take weeks to determine how infectious the variant is, whether it causes more severe illness and how effective treatments and vaccines are against it. “We’re going to get the answers that everybody out...
Omicron reportedly has 30+ mutations in spike protein region, may bypass vaccines: AIIMS chief

Omicron reportedly has 30+ mutations in spike protein region, may bypass vaccines: AIIMS chief

by AIP Online Bureau | Nov 28, 2021 | Eco/Invest/Demography, Health, Indian News, Pandemic, Workplace/Employee Benefits

AIIMS chief Dr Randeep Guleria The future course of action will depend on what more data on its transmissibility, virulence and immunoescpae shows, AIIMS chief Dr Randeep Guleria said. The Indian SARS-CoV-2 Genomic Consortia INSACOG is closely tracking the new variant...

Explainer: How worried should we be about the Omicron variant?

by AIP Online Bureau | Nov 27, 2021 | Eco/Invest/Demography, Health, International News, Pandemic, Policy, Workplace/Employee Benefits

Omicron’s mutations are likely to render certain COVID-19 treatments – including some manufactured antibodies – ineffective, said Dr. David Ho, professor of microbiology and immunology at Columbia University. Experimental antiviral pills – such...
Next Entries »

Recent Posts

  • Agri minister Chouhan reviews crop loss and insurance claims to farmers
  • US allies see no way of opening Hormuz Strait during war
  • US sending Marines and amphibious assault ship to Middle East, officials say
  • Indian gas tankers getting ready to sail through Hormuz, data shows
  • Credit Guarantee Scheme for MFIs approved

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy